Estimated GFR (eGFR) at Dr. Essa Lab

Estimated GFR (eGFR) at Dr. Essa Lab

The Estimated Glomerular Filtration Rate (eGFR) is a fundamental diagnostic blood test used to evaluate how efficiently the kidneys filter waste products from the bloodstream. Glomeruli are the microscopic tufts of capillaries within the kidneys that act as primary filtering units. The rate at which these specialized structures filter blood is known as the Glomerular Filtration Rate (GFR). Because directly measuring GFR is highly complex and clinically impractical for routine monitoring, medical laboratories utilize the estimated GFR (eGFR). This calculation is derived from the concentration of serum creatinine—a metabolic waste product of muscle breakdown—alongside key demographic variables such as age, biological sex, and sometimes body surface area.

At Dr. Essa Lab, a premier diagnostic institution in Karachi, Pakistan, the eGFR test is performed using state-of-the-art automated chemistry analyzers. By utilizing standardized mathematical equations, such as the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, Dr. Essa Lab provides highly accurate assessments of renal function. This test is of paramount clinical importance because chronic kidney disease (CKD) often progresses silently, presenting no noticeable symptoms until significant, irreversible damage has occurred. Early detection through routine eGFR testing allows nephrologists and primary care physicians to implement therapeutic interventions that can halt or significantly slow the progression of renal decline, thereby preventing complications such as end-stage renal disease (ESRD), cardiovascular events, and severe electrolyte imbalances.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest degree of clinical accuracy and to prevent transient fluctuations in serum creatinine levels, patients are advised to follow specific preparation guidelines prior to undergoing an eGFR test at Dr. Essa Lab:

• Hydration: Maintain adequate fluid intake. Dehydration can cause a temporary elevation in serum creatinine, leading to an artificially low eGFR calculation.
• Dietary Restrictions: Avoid consuming large quantities of cooked meat (especially beef) for at least 24 hours before the blood draw. Digested meat can temporarily elevate blood creatinine levels.
• Avoid Creatine Supplements: Discontinue the use of creatine-containing fitness supplements for several days prior to the test, as these directly influence creatinine levels.
• Physical Activity: Avoid strenuous, high-intensity muscular exercise for 24 hours before the test, as intense muscle exertion increases creatinine release into the bloodstream.
• Medication Review: Inform your prescribing physician and the laboratory staff of all current medications, particularly antibiotics (like trimethoprim) or acid-reducing drugs (like cimetidine), which can interfere with renal tubular secretion of creatinine.

During the Procedure

The eGFR test is a straightforward, minimally invasive laboratory investigation requiring a standard venous blood sample. Upon arriving at a Dr. Essa Lab collection center, the patient is seated comfortably. A certified phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm. The site is thoroughly cleansed with an antiseptic swab. A sterile tourniquet is applied to restrict venous blood flow, making the vein more prominent. A sterile, single-use needle is gently inserted, and the blood is collected into a gold-top serum separator tube (SST) or a red-top tube. Once the collection is complete, the needle is withdrawn, and gentle pressure is applied to the puncture site with a sterile cotton ball to prevent hematoma formation. The entire procedure takes less than five minutes, with minimal discomfort described as a brief pinch.

When is an Estimated GFR (eGFR) Performed?

Chronic Kidney Disease (CKD) Screening

Physicians routinely order an eGFR test to screen individuals who possess high-risk factors for developing chronic kidney disease. Because early-stage renal impairment is asymptomatic, routine screening is the only reliable method for early detection. This is particularly vital for patients with long-standing systemic metabolic conditions.

Monitoring Known Renal Impairment

For patients already diagnosed with chronic kidney disease or acute kidney injury (AKI), the eGFR test is performed at regular intervals to monitor the rate of disease progression. It assists nephrologists in determining the stage of kidney disease, evaluating the efficacy of therapeutic interventions, and adjusting treatment plans accordingly.

Evaluation of Unexplained Fatigue and Edema

When patients present with clinical symptoms suggestive of fluid retention, such as peripheral edema (swelling in the ankles, feet, or hands), puffiness around the eyes, unexplained chronic fatigue, or changes in urinary frequency and color, an eGFR test is indicated. These symptoms often point to impaired renal filtration and subsequent uremic toxin accumulation.

Assessment Prior to Administering Nephrotoxic Medications

Before initiating therapies involving potentially nephrotoxic drugs—such as certain chemotherapeutic agents, long-term nonsteroidal anti-inflammatory drugs (NSAIDs), specific antibiotics, or intravenous contrast media for CT scans—clinicians require an eGFR baseline. This ensures the kidneys can safely clear the substances without sustaining acute damage.

Management of Hypertension and Diabetes Mellitus

Hypertension and diabetes are the leading causes of renal microvascular damage. Regular eGFR testing is a standard component of the annual diabetic and hypertensive care package at Dr. Essa Lab, allowing clinicians to detect the earliest signs of diabetic nephropathy or hypertensive nephrosclerosis.

What Does an Estimated GFR (eGFR) Detect?

The eGFR calculation serves as a highly sensitive indicator of renal health. Specifically, it assists in identifying and classifying the following clinical conditions and physiological states:

• Normal Kidney Function: An eGFR value of 90 mL/min/1.73m² or higher indicates healthy, fully functioning kidneys, provided there are no other signs of renal damage.
• Stage 1 Chronic Kidney Disease: Indicated by a normal eGFR (≥ 90 mL/min/1.73m²) but with documented structural kidney damage, such as persistent proteinuria or abnormal imaging.
• Stage 2 Chronic Kidney Disease: Characterized by a mild reduction in filtration capacity, with an eGFR ranging between 60 and 89 mL/min/1.73m² alongside evidence of kidney damage.
• Stage 3a Chronic Kidney Disease: Represents a mild-to-moderate decrease in renal function, with an eGFR between 45 and 59 mL/min/1.73m².
• Stage 3b Chronic Kidney Disease: Represents a moderate-to-severe decrease in renal function, with an eGFR between 30 and 44 mL/min/1.73m².
• Stage 4 Chronic Kidney Disease: A severe reduction in kidney function, indicated by an eGFR of 15 to 29 mL/min/1.73m², requiring preparation for renal replacement therapy.
• Stage 5 Chronic Kidney Disease (Kidney Failure): An eGFR of less than 15 mL/min/1.73m², indicating established kidney failure where dialysis or a kidney transplant is necessary for survival.
• Acute Kidney Injury (AKI): A sudden, rapid decline in eGFR from baseline, often triggered by severe dehydration, sepsis, shock, or nephrotoxic drugs.
• Diabetic Nephropathy: Renal damage secondary to chronic hyperglycemia, initially detected through microalbuminuria and monitored via progressive eGFR decline.
• Hypertensive Nephrosclerosis: Kidney damage caused by chronic, uncontrolled high blood pressure, leading to ischemic changes in the glomeruli.
• Glomerulonephritis: Inflammation of the kidney’s filtering units, resulting in a sudden or progressive drop in eGFR.
• Polycystic Kidney Disease (PKD): A genetic disorder characterized by fluid-filled cysts that progressively destroy surrounding functional renal parenchyma.
• Lupus Nephritis: Systemic lupus erythematosus (SLE) autovascular damage affecting the kidneys, monitored closely via eGFR.
• Interstitial Nephritis: Inflammation of the spaces between renal tubules, often drug-induced, causing acute drops in eGFR.
• Pyelonephritis: Severe, complicated upper urinary tract infections that can temporarily impair renal filtration.
• Post-Renal Obstruction Effects: Backpressure on the kidneys caused by kidney stones, benign prostatic hyperplasia (BPH), or tumors, leading to decreased filtration.
• Renal Artery Stenosis: Narrowing of the arteries supplying the kidneys, reducing perfusion pressure and lowering eGFR.
• Preeclampsia-Related Renal Impairment: Gestational hypertension complications affecting maternal kidney function.
• Amyloidosis: Abnormal protein deposits in renal tissues leading to progressive filtration failure.
• Myeloma Kidney: Renal damage caused by light chain cast nephropathy in multiple myeloma, leading to rapid eGFR decline.
• Contrast-Induced Nephropathy (CIN): Acute impairment of renal function following the administration of intravascular contrast media.
• Drug-Induced Nephrotoxicity: Impairment caused by medications like aminoglycosides, amphotericin B, or calcineurin inhibitors.
• Age-Related Decline in GFR: Natural, gradual physiological reduction in nephron mass and filtration rate in elderly populations.
• Dehydration-Induced Prerenal Azotemia: Temporary reduction in renal perfusion leading to a reversible decline in eGFR.
• Cardiorenal Syndrome: Concomitant dysfunction of the heart and kidneys, where cardiac failure leads to renal hypoperfusion.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to providing rapid, accurate, and highly accessible diagnostic reporting. For a routine blood test such as the eGFR, the turnaround time is typically within 12 to 24 hours from the time of sample collection. Once the clinical pathologists verify the results, patients receive an automated SMS notification. Reports can be accessed online through the official Dr. Essa Lab web portal, via their dedicated mobile application, or directly through WhatsApp. Physical copies of the reports can also be collected from any of their conveniently located diagnostic centers across Karachi and other major cities.

Estimated GFR (eGFR) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
eGFR (Glomerular Filtration Rate)	≥ 90 mL/min/1.73m²	< 60 mL/min/1.73m² (indicates chronic kidney disease if sustained for ≥ 3 months)
Serum Creatinine	0.6 to 1.2 mg/dL (adult males); 0.5 to 1.1 mg/dL (adult females)	Elevated levels (suggests impaired renal clearance or acute muscle injury)
Blood Urea Nitrogen (BUN)	7 to 20 mg/dL	Elevated (uremia due to renal failure, dehydration, or high protein intake)
BUN-to-Creatinine Ratio	10:1 to 20:1	> 20:1 (suggests prerenal causes like dehydration); < 10:1 (suggests intrinsic renal damage)
Electrolyte Balance (Potassium)	3.5 to 5.0 mEq/L	Hyperkalemia (> 5.0 mEq/L) commonly associated with advanced renal filtration failure
Electrolyte Balance (Phosphorus)	2.5 to 4.5 mg/dL	Hyperphosphatemia (> 4.5 mg/dL) due to decreased renal excretion
Acid-Base Status (Bicarbonate)	22 to 29 mEq/L	Metabolic acidosis (< 22 mEq/L) due to the kidneys’ inability to excrete hydrogen ions

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Estimated GFR (eGFR)?

• Experienced Healthcare Professionals: Highly qualified pathologists and laboratory technologists oversee all testing procedures.
• Patient-Focused Care: Dedicated staff members ensure a comfortable, stress-free experience during sample collection.
• Quality Diagnostic Services: Adherence to strict internal and external quality control protocols for precise results.
• Professional Reporting: Clear, comprehensive, and easy-to-understand diagnostic reports.
• Modern Diagnostic Approach: Utilization of advanced, fully automated chemistry analyzers for high-throughput testing.
• Comfortable Environment: Clean, hygienic, and welcoming diagnostic centers designed with patient comfort in mind.
• Convenient Location: An extensive network of collection points across Karachi and beyond, making access effortless.
• Commitment to Accurate Diagnosis: Decades of trusted service in Pakistan, ensuring clinical integrity in every test performed.